During the past decade, Services des Maladies Infectieuses conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Services des Maladies Infectieuses" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "French National Agency for Research on AIDS and Viral Hepatitis" with 1 trials sponsored, "Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Services des Maladies Infectieuses" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Glaxo Wellcome" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Services des Maladies Infectieuses" are "HIV Infections" (6 trials), "HIV" (2 trials), "Chlamydia Trachomatis Infection" (1 trials), "Cytomegalovirus Infections" (1 trials) and "Mycoplasma Genitalium Infection" (1 trials). Many other conditions were trialed in "Services des Maladies Infectieuses" in a lesser frequency.

Most popular intervention types in "Services des Maladies Infectieuses" are "Drug" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (2 trials), "Atazanavir" (2 trials), "FTC/TDF" (2 trials), "ATV Placebo" (1 trials) and "Acyclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Services des Maladies Infectieuses" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Services des Maladies Infectieuses". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Services des Maladies Infectieuses, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Services des Maladies Infectieuses, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".